94 related articles for article (PubMed ID: 1294532)
1. MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21ras) levels in human breast tumors.
Solana R; Romero J; Alonso C; Peña J
Invasion Metastasis; 1992; 12(3-4):210-7. PubMed ID: 1294532
[TBL] [Abstract][Full Text] [Related]
2. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
3. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
4. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
5. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
[TBL] [Abstract][Full Text] [Related]
6. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells.
Pantel K; Schlimok G; Kutter D; Schaller G; Genz T; Wiebecke B; Backmann R; Funke I; Riethmüller G
Cancer Res; 1991 Sep; 51(17):4712-5. PubMed ID: 1873815
[TBL] [Abstract][Full Text] [Related]
7. Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas.
Redondo M; Concha A; Ruiz-Cabello F; Morell M; Esteban F; Talavera P; Garrido F
Cancer Detect Prev; 1997; 21(1):22-8. PubMed ID: 9043759
[TBL] [Abstract][Full Text] [Related]
8. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer.
Clair T; Miller WR; Cho-Chung YS
Cancer Res; 1987 Oct; 47(20):5290-3. PubMed ID: 3308076
[TBL] [Abstract][Full Text] [Related]
10. MHC expression on human tumors--its relevance for local tumor growth and metastasis.
Garrido F; Ruiz-Cabello F
Semin Cancer Biol; 1991 Feb; 2(1):3-10. PubMed ID: 1912516
[TBL] [Abstract][Full Text] [Related]
11. HLA expression in basal cell carcinomas.
Garcia-Plata D; Mozos E; Sierra MA; Peña J; Solana R
Invasion Metastasis; 1991; 11(3):166-73. PubMed ID: 1834604
[TBL] [Abstract][Full Text] [Related]
12. T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.
Peace DJ; Chen W; Nelson H; Cheever MA
J Immunol; 1991 Mar; 146(6):2059-65. PubMed ID: 2005390
[TBL] [Abstract][Full Text] [Related]
13. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma.
Krishnakumar S; Sundaram A; Abhyankar D; Krishnamurthy V; Shanmugam MP; Gopal L; Sharma T; Biswas J
Cancer; 2004 Mar; 100(5):1059-69. PubMed ID: 14983503
[TBL] [Abstract][Full Text] [Related]
15. HLA-G is a potential tumor marker in malignant ascites.
Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.
Oldford SA; Robb JD; Codner D; Gadag V; Watson PH; Drover S
Int Immunol; 2006 Nov; 18(11):1591-602. PubMed ID: 16987935
[TBL] [Abstract][Full Text] [Related]
17. A retroviral vector expressing human interferon gamma upregulates MHC antigen expression in human breast cancer and leukemia cell lines.
Cornetta K; Berebitsky D; Behnia M; Traycoff C; Srour EF; Sledge GW
Cancer Gene Ther; 1994 Jun; 1(2):91-8. PubMed ID: 7621246
[TBL] [Abstract][Full Text] [Related]
18. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
20. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
Ryschich E; Nötzel T; Hinz U; Autschbach F; Ferguson J; Simon I; Weitz J; Fröhlich B; Klar E; Büchler MW; Schmidt J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):498-504. PubMed ID: 15701833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]